| Product Code: ETC13117621 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Latvia continued to heavily rely on imports of pneumococcal vaccines, with top exporting countries including Metropolitan France, Germany, Lithuania, Poland, and the USA. The market concentration, as measured by the HHI, remained very high, indicating a dominance of these key exporting nations. Despite a high compound annual growth rate (CAGR) of 43.42% from 2020 to 2024, there was a significant decline in growth rate from 2023 to 2024 at -57.01%. This suggests a potential shift or challenges in the market dynamics that may require further analysis and strategic considerations for stakeholders in the pneumococcal vaccine import industry in Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Pneumococcal Vaccines Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Pneumococcal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Pneumococcal Vaccines Market - Industry Life Cycle |
3.4 Latvia Pneumococcal Vaccines Market - Porter's Five Forces |
3.5 Latvia Pneumococcal Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Pneumococcal Vaccines Market Revenues & Volume Share, By Vaccine Technology, 2021 & 2031F |
3.7 Latvia Pneumococcal Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Latvia Pneumococcal Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Latvia Pneumococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Latvia |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Rising prevalence of pneumococcal infections in the country |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas |
4.3.2 High cost associated with pneumococcal vaccines |
4.3.3 Vaccine hesitancy among certain population groups |
5 Latvia Pneumococcal Vaccines Market Trends |
6 Latvia Pneumococcal Vaccines Market, By Types |
6.1 Latvia Pneumococcal Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Conjugate, 2021 - 2031F |
6.1.4 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2021 - 2031F |
6.1.5 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Combination, 2021 - 2031F |
6.1.6 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Live Attenuated, 2021 - 2031F |
6.1.7 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Latvia Pneumococcal Vaccines Market, By Vaccine Technology |
6.2.1 Overview and Analysis |
6.2.2 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Protein-based, 2021 - 2031F |
6.2.3 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Recombinant, 2021 - 2031F |
6.2.4 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Inactivated, 2021 - 2031F |
6.2.5 Latvia Pneumococcal Vaccines Market Revenues & Volume, By mRNA-based, 2021 - 2031F |
6.2.6 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Latvia Pneumococcal Vaccines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Government, 2021 - 2031F |
6.3.5 Latvia Pneumococcal Vaccines Market Revenues & Volume, By NGOs, 2021 - 2031F |
6.3.6 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 Latvia Pneumococcal Vaccines Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Immunization, 2021 - 2031F |
6.4.3 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Disease Prevention, 2021 - 2031F |
6.4.4 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Pediatric Vaccination, 2021 - 2031F |
6.4.5 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Elderly Care, 2021 - 2031F |
6.4.6 Latvia Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
7 Latvia Pneumococcal Vaccines Market Import-Export Trade Statistics |
7.1 Latvia Pneumococcal Vaccines Market Export to Major Countries |
7.2 Latvia Pneumococcal Vaccines Market Imports from Major Countries |
8 Latvia Pneumococcal Vaccines Market Key Performance Indicators |
8.1 Percentage of population vaccinated against pneumococcal diseases |
8.2 Number of government-supported vaccination campaigns |
8.3 Rate of pneumococcal infections in Latvia |
9 Latvia Pneumococcal Vaccines Market - Opportunity Assessment |
9.1 Latvia Pneumococcal Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Pneumococcal Vaccines Market Opportunity Assessment, By Vaccine Technology, 2021 & 2031F |
9.3 Latvia Pneumococcal Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Latvia Pneumococcal Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Latvia Pneumococcal Vaccines Market - Competitive Landscape |
10.1 Latvia Pneumococcal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Latvia Pneumococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here